The conclusion from two massive studies of the possibility that antioxidant supplements might ward off prostate cancer was so rock solid that the research teams released their findings way ahead of schedule, citing public health implications as their reason for…

Doctors measure a man’s level of prostate-specific antigen (PSA) to screen for prostate cancer.  The higher the concentration of PSA, the higher the possibility of prostate cancer.  The findings of a study, published today in the medical journal, Cancer, suggests…

Duke University Medical Center’s Prostate Center has just released the outcome of their survey that explored the prevalence of PSA screening tests in men younger than 50.  A recent study suggesting men who are not expected to live 10 more…

One of the most widely used prostate cancer screening techniques can detect cancer many years before other evidence of the disease develops.  Prostate cancer is a slow-growing cancer, often taking ten years or longer to become evident.  It is the…

A retrospective review of hundreds of patients diagnosed with recurring prostate cancer has revealed a surprising outcome and it includes good news for men who suffer from even the most aggressive forms of the disease.  It seems that longevity increases…

Italian researchers have just announced the impressive findings of a study using an oral medication to combat attacks of the disease and prolong the time between relapses.  The most effective drugs used today - beta interferon and glatiramer - reduce…

Working with the popular drugs Celebrex and Lipitor, researchers have demonstrated how the combination of these two drugs has halted the advance of prostate cancer from stage one into a more advanced, potentially lethal, stage of the disease.

Modern biopsy techniques appear to have made Prostate Specific Antigen (PSA) testing less useful in men with a normal digital rectal exam. PSA testing has been commonly used to help physicians detect prostate cancer. Although the test was not entirely…

A study done by Duke University Medical Center researchers found that overweight or obese men had lower concentrations of prostate-specific antigen (PSA) in their blood than normal weight men. PSA is a protein released into the blood by the prostate…

Scientists may have found a better way to predict the eventual onset of prostate cancer. Men who have not yet reached the age of 50 can now be tested with a single PSA test which may help to determine if…